Avanos Medical (AVNS) Enterprise Value Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.37% |
| Dec 31, 2025 | 16.62% |
| Sep 30, 2025 | 20.79% |
| Jun 30, 2025 | 2.06% |
| Mar 31, 2025 | -27.97% |
| Dec 31, 2024 | -22.81% |
| Sep 30, 2024 | 16.90% |
| Jun 30, 2024 | -12.71% |
| Mar 31, 2024 | 20.79% |
| Dec 31, 2023 | 31.32% |
| Sep 30, 2023 | 8.46% |
| Jun 30, 2023 | 23.19% |
| Mar 31, 2023 | 8.25% |
| Dec 31, 2022 | -7.76% |
| Sep 30, 2022 | -19.63% |
| Jun 30, 2022 | -6.61% |
| Mar 31, 2022 | -4.20% |
| Dec 31, 2021 | -6.28% |
| Sep 30, 2021 | 45.67% |
| Jun 30, 2021 | 46.00% |
| Mar 31, 2021 | 46.67% |
| Dec 31, 2020 | 45.69% |
| Sep 30, 2020 | 16.04% |
| Jun 30, 2020 | 35.79% |
| Mar 31, 2020 | 46.11% |
| Dec 31, 2019 | 46.61% |
| Sep 30, 2019 | 47.94% |
| Jun 30, 2019 | 45.75% |
| Mar 31, 2019 | -71.49% |
| Dec 31, 2018 | -75.01% |
| Sep 30, 2018 | -147.92% |
| Jun 30, 2018 | -243.09% |
| Mar 31, 2018 | -41.93% |
| Dec 31, 2017 | -93.23% |
| Sep 30, 2017 | -91.58% |
| Jun 30, 2017 | -95.45% |
| Mar 31, 2017 | 13.33% |
| Dec 31, 2016 | 12.20% |
| Sep 30, 2016 | 22.93% |
| Jun 30, 2016 | 30.71% |
| Mar 31, 2016 | 0.66% |
| Dec 31, 2015 | 13.09% |
| Sep 30, 2015 | -92.64% |
| Jun 30, 2015 | -135.67% |
| Mar 31, 2015 | -364.25% |
| Dec 31, 2014 | -237.87% |
| Sep 30, 2014 | -32.73% |